General Information of the Protein
Protein ID
PT00870
Protein Name
Glucocorticoid receptor
Secondarily
Protein Name
Nuclear receptor subfamily 3 group C member 1
Gene Name
NR3C1
Secondarily
Gene Name
Grl
Sequence
MDSKESLAPPGRDEVPGSLLGQGRGSVMDFYKSLRGGATVKVSASSPSVAAASQADSKQQRILLDFSKGSTSNVQQRQQQQQQQQQQQQQQQQQQQPDLSKAVSLSMGLYMGETETKVMGNDLGYPQQGQLGLSSGETDFRLLEESIANLNRSTSVPENPKSSTSATGCATPTEKEFPKTHSDASSEQQNRKSQTGTNGGSVKLYPTDQSTFDLLKDLEFSAGSPSKDTNESPWRSDLLIDENLLSPLAGEDDPFLLEGNTNEDCKPLILPDTKPKIKDTGDTILSSPSSVALPQVKTEKDDFIELCTPGVIKQEKLGPVYCQASFSGTNIIGNKMSAISVHGVSTSGGQMYHYDMNTASLSQQQDQKPVFNVIPPIPVGSENWNRCQGSGEDSLTSLGALNFPGRSVFSNGYSSPGMRPDVSSPPSSSSAATGPPPKLCLVCSDEASGCHYGVLTCGSCKVFFKRAVEGQHNYLCAGRNDCIIDKIRRKNCPACRYRKCLQAGMNLEARKTKKKIKGIQQATAGVSQDTSENPNKTIVPAALPQLTPTLVSLLEVIEPEVLYAGYDSSVPDSAWRIMTTLNMLGGRQVIAAVKWAKAILGLRNLHLDDQMTLLQYSWMFLMAFALGWRSYRQSSGNLLCFAPDLIINEQRMSLPCMYDQCKHMLFVSSELQRLQVSYEEYLCMKTLLLLSSVPKEGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEVVENLLTYCFQTFLDKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK
    Show/Hide
Organism
Rattus norvegicus, Rat
Protein Classification
Transcription factor
>
Nuclear receptor
>
Nuclear hormone receptor subfamily 3
>
Nuclear hormone receptor subfamily 3 group C
>
Nuclear hormone receptor subfamily 3 group C member 1
Function
Receptor for glucocorticoids (GC). Has a dual mode of action: as a transcription factor that binds to glucocorticoid response elements (GRE), both for nuclear and mitochondrial DNA, and as a modulator of other transcription factors. Affects inflammatory responses, cellular proliferation and differentiation in target tissues. Involved in chromatin remodeling (PubMed:12917342). Plays a role in rapid mRNA degradation by binding to the 5' UTR of target mRNAs and interacting with PNRC2 in a ligand-dependent manner which recruits the RNA helicase UPF1 and the mRNA-decapping enzyme DCP1A, leading to RNA decay (By similarity). Could act as a coactivator for STAT5-dependent transcription upon growth hormone (GH) stimulation and could reveal an essential role of hepatic GR in the control of body growth (By similarity). In response to induction by transcription factor EGR1/NGFI-A in the hippocampus, may play a role in the behavioral and hypothalamic-pituitary-adrenal responses to stress in offspring (PubMed:15220929).
    Show/Hide
Uniprot ID
Primary ID:
P06536

Secondarily ID:
O08624
Q8R463
Q8R5J0
    Show/Hide
Ensembl ID
ENSG00000113580
Subcellular Location
Cytoplasm
Nucleus
Mitochondrion
Cytoplasm
Cytoskeleton
Spindle
Cytoplasm
Cytoskeleton
Microtubule organizing center
Centrosome
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000298 , H4-II-E
Compound ID Compound Name Compound Formula
CP0070809
CCI-18781
   Show/Hide
C25H31F3O5S
 1
1
EC50 = 0.76 nM
   TI
   LI
   LO
   TS
CP0393622
[(8S,9S,10R,11S,13S,14S,17R)-17-[2-(1,3-benzothiazol-2-ylsulfanyl)acetyl]-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
   Show/Hide
C33H33NO6S2
 1
1
EC50 = 18.7 nM
   TI
   LI
   LO
   TS
CP0238565
(6S,8S,9R,10S,11S,13S,14S,16R,17R)-17-[2-(1,3-benzothiazol-2-ylsulfanyl)acetyl]-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
   Show/Hide
C29H31F2NO4S2
 1
1
EC50 = 27 nM
   TI
   LI
   LO
   TS
CP0035186
(10S,11S,14S,15S,17R)-17-[4-(dimethylamino)phenyl]-14-hydroxy-15-methyl-14-(prop-1-yn-1-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1,6-dien-5-one
   Show/Hide
C29H35NO2
 1
1
IC50 = 1.94 nM
   TI
   LI
   LO
   TS
CP0416607
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-hydroxyethanone
   Show/Hide
C28H33FN2O4
 1
1
IC50 = 3.2 nM
   TI
   LI
   LO
   TS
CP0416614
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-hydroxyethanone
   Show/Hide
C28H34N2O4
 1
1
IC50 = 3.23 nM
   TI
   LI
   LO
   TS
CP0380981
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-pyridin-2-ylsulfanylethanone
   Show/Hide
C33H36FN3O3S
 1
1
IC50 = 4.5 nM
   TI
   LI
   LO
   TS
CP0444548
N-[2-[[benzyl(methyl)amino]methyl]-3-(4-fluoro-2-methoxyphenyl)-5-propan-2-yl-1H-indol-7-yl]methanesulfonamide
   Show/Hide
C28H32FN3O3S
 1
1
IC50 = 10.6 nM
   TI
   LI
   LO
   TS
CP0400170
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-([1,3]oxazolo[4,5-b]pyridin-2-ylsulfanyl)ethanone
   Show/Hide
C34H35FN4O4S
 1
1
IC50 = 13.3 nM
   TI
   LI
   LO
   TS
CP0416609
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-pyrimidin-2-ylsulfanylethanone
   Show/Hide
C32H35FN4O3S
 1
1
IC50 = 14.3 nM
   TI
   LI
   LO
   TS
CP0410986
N-[2-[[benzyl(methyl)amino]methyl]-5-tert-butyl-3-(4-fluoro-2-methoxyphenyl)-1H-indol-7-yl]methanesulfonamide
   Show/Hide
C29H34FN3O3S
 1
1
IC50 = 14.4 nM
   TI
   LI
   LO
   TS
CP0387981
(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-10,13,16-trimethyl-17-(2-quinolin-2-ylsulfanylacetyl)-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C31H35NO4S
 1
1
IC50 = 19.2 nM
   TI
   LI
   LO
   TS
CP0432716
(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-10,13,16-trimethyl-17-[2-([1,3]thiazolo[5,4-b]pyridin-2-ylsulfanyl)acetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C28H32N2O4S2
 1
1
IC50 = 24.1 nM
   TI
   LI
   LO
   TS
CP0400172
2-(1,3-benzothiazol-2-ylsulfanyl)-1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]ethanone
   Show/Hide
C35H36FN3O3S2
 1
1
IC50 = 24.1 nM
   TI
   LI
   LO
   TS
CP0400173
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-quinolin-2-ylsulfanylethanone
   Show/Hide
C37H38FN3O3S
 1
1
IC50 = 24.3 nM
   TI
   LI
   LO
   TS
CP0428604
2-(1,3-benzoxazol-2-ylsulfanyl)-1-[(1S,2R,13S,14S,17R,18S,20S)-7-cyclohexyl-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]ethanone
   Show/Hide
C35H43N3O4S
 1
1
IC50 = 31.6 nM
   TI
   LI
   LO
   TS
CP0400175
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-([1,3]oxazolo[4,5-b]pyridin-2-ylsulfanyl)ethanone
   Show/Hide
C34H36N4O4S
 1
1
IC50 = 33.8 nM
   TI
   LI
   LO
   TS
CP0432419
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-quinolin-2-yloxyethanone
   Show/Hide
C37H38FN3O4
 1
1
IC50 = 44.7 nM
   TI
   LI
   LO
   TS
CP0400160
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-naphthalen-2-ylsulfanylethanone
   Show/Hide
C38H39FN2O3S
 1
1
IC50 = 52.5 nM
   TI
   LI
   LO
   TS
CP0400171
2-(1,3-benzothiazol-2-ylsulfanyl)-1-[(1S,2R,13S,14S,17R,18S,20S)-7-cyclohexyl-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]ethanone
   Show/Hide
C35H43N3O3S2
 1
1
IC50 = 54.7 nM
   TI
   LI
   LO
   TS
CP0380940
2-(1,3-benzothiazol-2-ylsulfanyl)-1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]ethanone
   Show/Hide
C35H37N3O3S2
 1
1
IC50 = 57.3 nM
   TI
   LI
   LO
   TS
CP0416608
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-naphthalen-2-yloxyethanone
   Show/Hide
C38H39FN2O4
 1
1
IC50 = 58 nM
   TI
   LI
   LO
   TS
CP0413727
N-[5-fluoro-3-(4-fluoro-2-methoxyphenyl)-2-methyl-1H-indol-7-yl]methanesulfonamide
   Show/Hide
C17H16F2N2O3S
 1
1
IC50 = 63.4 nM
   TI
   LI
   LO
   TS
CP0047174
(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one
   Show/Hide
C21H28O5
 1
1
IC50 = 65.4 nM
   TI
   LI
   LO
   TS
CP0380980
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-isoquinolin-1-ylsulfanylethanone
   Show/Hide
C37H38FN3O3S
 1
1
IC50 = 65.4 nM
   TI
   LI
   LO
   TS
CP0413728
N-[3-(3-chlorophenyl)-1H-indol-7-yl]methanesulfonamide
   Show/Hide
C15H13ClN2O2S
 1
1
IC50 = 76 nM
   TI
   LI
   LO
   TS
CP0410217
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-(1-methylbenzimidazol-2-yl)sulfanylethanone
   Show/Hide
C36H40N4O3S
 1
1
IC50 = 78 nM
   TI
   LI
   LO
   TS
CP0416612
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-(1-methylbenzimidazol-2-yl)oxyethanone
   Show/Hide
C36H39FN4O4
 1
1
IC50 = 78 nM
   TI
   LI
   LO
   TS
CP0400177
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-quinolin-2-ylsulfanylethanone
   Show/Hide
C37H39N3O3S
 1
1
IC50 = 82.3 nM
   TI
   LI
   LO
   TS
CP0385331
2-(1,3-benzothiazol-2-yloxy)-1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]ethanone
   Show/Hide
C35H36FN3O4S
 1
1
IC50 = 84 nM
   TI
   LI
   LO
   TS
CP0385328
2-[2-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-oxoethyl]sulfanyl-3H-quinazolin-4-one
   Show/Hide
C36H37FN4O4S
 1
1
IC50 = 86.5 nM
   TI
   LI
   LO
   TS
CP0416610
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-quinoxalin-2-ylsulfanylethanone
   Show/Hide
C36H38N4O3S
 1
1
IC50 = 113 nM
   TI
   LI
   LO
   TS
CP0401463
(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-10,13,16-trimethyl-17-[2-([1,3]oxazolo[4,5-b]pyridin-2-ylsulfanyl)acetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C28H32N2O5S
 1
1
IC50 = 135 nM
   TI
   LI
   LO
   TS
CP0446952
1-[(1S,2R,13S,14S,17R,18S,20S)-7-cyclohexyl-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-[(4,5-dimethyl-1,3-thiazol-2-yl)sulfanyl]ethanone
   Show/Hide
C33H45N3O3S2
 1
1
IC50 = 135 nM
   TI
   LI
   LO
   TS
CP0410216
1-[(1S,2R,13S,14S,17R,18S,20S)-7-(4-fluorophenyl)-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-(1-methylbenzimidazol-2-yl)sulfanylethanone
   Show/Hide
C36H39FN4O3S
 1
1
IC50 = 174 nM
   TI
   LI
   LO
   TS
CP0400174
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-pyridin-2-ylsulfanylethanone
   Show/Hide
C33H37N3O3S
 1
1
IC50 = 225 nM
   TI
   LI
   LO
   TS
CP0387984
(8S,9S,10R,11S,13S,14S,16R,17R)-17-[2-(1,3-benzothiazol-2-ylsulfanyl)acetyl]-11,17-dihydroxy-10,13,16-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C29H33NO4S2
 1
1
IC50 = 230 nM
   TI
   LI
   LO
   TS
CP0145473
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-[2-(1-methylbenzimidazol-2-yl)sulfanylacetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C29H34N2O4S
 1
1
IC50 = 235 nM
   TI
   LI
   LO
   TS
CP0434913
1-[(1S,2R,13S,14S,17R,18S,20S)-17,20-dihydroxy-2,18-dimethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone
   Show/Hide
C38H42N4O3S
 1
1
IC50 = 258 nM
   TI
   LI
   LO
   TS
CP0429171
N-[2-benzyl-3-(4-fluoro-2-methoxyphenyl)-5-propan-2-yl-1H-indol-7-yl]methanesulfonamide
   Show/Hide
C26H27FN2O3S
 1
1
IC50 = 292 nM
   TI
   LI
   LO
   TS
CP0385432
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-(2-quinolin-2-ylsulfanylacetyl)-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C30H33NO4S
 1
1
IC50 = 361 nM
   TI
   LI
   LO
   TS
CP0385431
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-(2-pyridin-2-ylsulfanylacetyl)-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C26H31NO4S
 1
1
IC50 = 707 nM
   TI
   LI
   LO
   TS
CP0427353
(8S,9S,10R,11S,13S,14S,16R,17R)-11,17-dihydroxy-10,13,16-trimethyl-17-[2-[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanyl]acetyl]-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
   Show/Hide
C30H34N2O5S
 1
1
IC50 = 740 nM
   TI
   LI
   LO
   TS
CP0409039
1-[(1S,2R,13S,14S,17R,18S,20S)-7-cyclohexyl-17,20-dihydroxy-2,18-dimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-yl]-2-(1-methylbenzimidazol-2-yl)sulfanylethanone
   Show/Hide
C36H46N4O3S
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0513116
N-[3-(2-methoxyphenyl)-1H-indol-7-yl]methanesulfonamide
   Show/Hide
C16H16N2O3S
 1
1
IC50 = 1180 nM
   TI
   LI
   LO
   TS
CP0416932
N-[3-(5-chloro-2-methoxyphenyl)-1H-indol-7-yl]methanesulfonamide
   Show/Hide
C16H15ClN2O3S
 1
1
IC50 = 1250 nM
   TI
   LI
   LO
   TS
CP0424441
2-[3,5-dibromo-4-[4-methoxy-2-(3-methylbenzoyl)-5-propan-2-ylphenoxy]phenyl]acetic acid
   Show/Hide
C26H24Br2O5
 1
1
IC50 = 2500 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0035186
(10S,11S,14S,15S,17R)-17-[4-(dimethylamino)phenyl]-14-hydroxy-15-methyl-14-(prop-1-yn-1-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1,6-dien-5-one
   Show/Hide
C29H35NO2
 2
1 EC50 = 2.512 nM
2 IC50 = 1.4 nM
CP0070809
CCI-18781
   Show/Hide
C25H31F3O5S
 2
1 IC50 = 0.14 nM
2 IC50 = 5 nM
CP0008077
(1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one
   Show/Hide
C22H29FO5
 1
1 IC50 = 22 nM
Similar Protein(s) and Bioactivity Statistics
90% Identity
Protein ID Protein Name Protein Organism
PT03331 Glucocorticoid receptor Mus musculus, Mouse
50% Identity
Protein ID Protein Name Protein Organism
PT00645 Glucocorticoid receptor Canis lupus familiaris, Dog, Canis familiaris
PT00967 Glucocorticoid receptor Homo sapiens, Human
PT07390 Glucocorticoid receptor Sus scrofa, Pig